SCHEMBL5256403

SCHEMBL5256403

O=C1Cn2c(c(C3CCCCC3)c3ccccc32)-c2ccccc2N1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.39
OPRD1 P41143 1/20 0.39
OPRK1 P41145 1/20 0.39
OGFRL1 Q5TC84 1/20 0.39
CCNB2 O95067 3/20 0.36
CDK1 P06493 3/20 0.36
CCNB1 P14635 3/20 0.36
GSK3B P49841 3/20 0.36
CCNB3 Q8WWL7 3/20 0.36
LRRK2 Q5S007 1/20 0.36
PARP1 P09874 1/20 0.36
CREBBP Q92793 2/20 0.35
ALDH1A1 P00352 1/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35
CCNT1 O60563 1/20 0.35
CCNA2 P20248 1/20 0.35
CDK2 P24941 1/20 0.35
CDK9 P50750 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL792582 0.87 CCNB2 (0.39) CCNB2CDK1CCNB1GSK3BCCNB3
SCHEMBL874916 0.84 PRKCA (0.50) CCNB2CDK1CCNB1GSK3BCCNB3
SCHEMBL14435330 0.82 PRKCA (0.43) CCNB2CDK1CCNB1GSK3BCCNB3
SCHEMBL925855 0.81 CDK1 (0.46) CCNB2CDK1CCNB1GSK3BCCNB3
SCHEMBL803645 0.80 PRKCA (0.35) CDK1
SCHEMBL14435944 0.79 SCN9A (0.43)
SCHEMBL9851857 0.78 GSK3B (0.40) CCNB2CDK1CCNB1GSK3BCCNB3
SCHEMBL9851860 0.78 CDK1 (0.44) CCNB2CDK1CCNB1GSK3BCCNB3
SCHEMBL14253194 0.77 SCN9A (0.62)
SCHEMBL792279 0.77 ARF6 (0.35) SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776368-A1 INHIBITORS OF HCV REPLICATION Bristol-Myers Squibb Company (US) 2007-04-25 EP disclosed
WO-2006020082-A1 INHIBITORS OF HCV REPLICATION BRISTOL-MYERS SQUIBB COMPANY (US) 2006-02-23 WO disclosed